Literature DB >> 15301996

Is insomnia best categorized as a symptom or a disease?

Michel Billiard1, Alison Bentley.   

Abstract

Insomnia, defined by difficulty falling asleep or remaining asleep, early morning awakening and/or non-restorative sleep, and daytime consequences, is an important public health issue with a significant negative impact on individuals' physical and social performance, ability to work and quality of life, as well as on society as a whole. Chronic insomnia warrants treatment in the majority of cases, but it is often under-treated. Primary insomnia occurs independently of other factors, and is possibly related to a general psychophysiologic hyperarousal. Other types of insomnia occur in association with various conditions such as psychiatric disorders, medical disorders (e.g., chronic pain, dysfunction and movement disorders), circadian rhythm disorders and medication or substance use. These types of insomnia are diagnosed more frequently in the clinic. As a result, insomnia is traditionally viewed and treated as a symptom rather than a disease, with the majority of therapies aimed at resolving underlying medical factors. However, it is important to clearly establish whether co-morbidities are causative for or simply co-exist with insomnia, in order to recommend the most appropriate treatment and optimize treatment outcomes. Difficulties still arise when categorizing insomnia subtypes. Here, we highlight some of the major challenges for future research in classifying both primary insomnia and insomnia related to or associated with various conditions, and their relevance to primary care.

Entities:  

Mesh:

Year:  2004        PMID: 15301996     DOI: 10.1016/s1389-9457(04)90006-8

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  6 in total

1.  Job stress and poor sleep quality: data from an American sample of full-time workers.

Authors:  Hannah K Knudsen; Lori J Ducharme; Paul M Roman
Journal:  Soc Sci Med       Date:  2007-03-23       Impact factor: 4.634

2.  New-onset insomnia among cancer patients undergoing chemotherapy: prevalence, risk factors, and its correlation with other symptoms.

Authors:  Huong Thi Xuan Hoang; Alex Molassiotis; Choi Wan Chan; Thi Huong Nguyen; Van Liep Nguyen
Journal:  Sleep Breath       Date:  2019-04-23       Impact factor: 2.816

3.  Sleep and quality of life in long-term lung cancer survivors.

Authors:  Nalaka S Gooneratne; Grace E Dean; Ann E Rogers; J Emeka Nkwuo; James C Coyne; Larry R Kaiser
Journal:  Lung Cancer       Date:  2007-08-31       Impact factor: 5.705

4.  A population-based investigation into the self-reported reasons for sleep problems.

Authors:  David Armstrong; Alex Dregan
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

5.  The Experience of Insomnia in Patients With Schizophrenic Disorder: A Qualitative Study.

Authors:  David Batalla-Martín; Maria-Antonia Martorell-Poveda; Angel Belzunegui-Eraso; Eva Miralles Garijo; Ana Del-Cuerpo Serratosa; JuanCarlos Valdearcos Pérez; Miquel Montané Escobar; Marina Lopez-Ruiz
Journal:  Front Psychiatry       Date:  2022-01-17       Impact factor: 4.157

6.  Genetic risk for subjective reports of insomnia associates only weakly with polygraphic measures of insomnia in 2,770 adults.

Authors:  Jonathan Foldager; Paul E Peppard; Erika W Hagen; Katie L Stone; Daniel S Evans; Gregory J Tranah; Helge Sørensen; Poul Jennum; Emmanuel Mignot; Logan D Schneider
Journal:  J Clin Sleep Med       Date:  2022-01-01       Impact factor: 4.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.